Joe Tippens' Journey with Cancer
- Joe Tippens, a 67-year-old businessman, was diagnosed with small cell lung cancer in August 2016.
- He underwent extensive chemotherapy and radiation, but treatments were harmful and nearly fatal.
- In January 2017, after a PET scan showed cancer spread to various body parts, his oncologist gave him only a few months to live.
Finding a Lifeline
- Tippens learned about fenbendazole, an antiparasitic drug, from a veterinarian's story about its success in treating cancer.
- Despite not being FDA-approved for humans, he decided to try it alongside conventional therapies.
- Tippens purchased Panacur, a brand of fenbendazole, over the counter.
- He followed a regimen of taking it for three days a week, becoming cancer-free after three months.
- His protocol also included Theracurmin and CBD.
Scientific Support and Mechanisms
- Dr. William Makis, an oncologist, reported numerous cases of patients becoming cancer-free using Tippens’s method.
- Anti-parasitic drugs like fenbendazole share traits with cancer cells, allowing them to combat cancer through various mechanisms:
- Boosting the p53 protein that kills cancer cells.
- Blocking glucose uptake, essential for cancer growth.
- Disrupting microtubules vital for cell division.
- Affecting mitochondrial function.
- Recent studies support fenbendazole's role in improving energy metabolism and starving cancer cells while sparing normal cells.
Patient Success Stories
- Donna Leland, diagnosed with Stage 3 cervical and endometrial cancer, opted out of chemotherapy and used fenbendazole and ivermectin instead.
- Leland and her practitioner, Terry Harmon, reported multiple positive outcomes from these treatments, attributing success to improved immunity and addressing infections.
- Leland is now cancer-free and feels rejuvenated due to these alternative treatments.
Global Impact
- The "Joe Tippens Protocol" has gained international attention, particularly in China, with millions viewing his translated blog.
- Tippens refuses to monetize his discovery, emphasizing trust from those he helps.
Regulatory and Medical Challenges
- The FDA has not approved fenbendazole for humans, and although ivermectin is approved for other uses, it is not recognized for cancer treatment.
- Both drugs are accessible without prescriptions and often used in veterinary practice.
- Makis advocates for exploring these repurposed drugs, promoting medical freedom in treatment options.
Encouraging Ongoing Research
- Tippens is hopeful for future research into anti-parasitic drugs for cancer treatment.
- There are several related drugs to fenbendazole that might offer further therapeutic benefits.
No comments:
Post a Comment